Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 626.86 | 1445 / 1445 | 100% | 5.33 | 183 / 183 |
prostate | 100% | 650.99 | 245 / 245 | 100% | 7.52 | 502 / 502 |
stomach | 100% | 457.00 | 359 / 359 | 100% | 5.57 | 286 / 286 |
brain | 100% | 647.54 | 2640 / 2642 | 100% | 5.44 | 705 / 705 |
uterus | 100% | 522.88 | 170 / 170 | 100% | 5.63 | 458 / 459 |
breast | 100% | 410.65 | 459 / 459 | 100% | 4.88 | 1115 / 1118 |
thymus | 100% | 610.65 | 653 / 653 | 100% | 5.98 | 603 / 605 |
ovary | 99% | 312.84 | 179 / 180 | 100% | 7.64 | 430 / 430 |
lung | 100% | 396.60 | 576 / 578 | 100% | 4.44 | 1152 / 1155 |
pancreas | 99% | 272.70 | 326 / 328 | 100% | 3.99 | 178 / 178 |
intestine | 100% | 695.01 | 966 / 966 | 99% | 6.28 | 523 / 527 |
bladder | 100% | 550.05 | 21 / 21 | 99% | 5.98 | 499 / 504 |
kidney | 100% | 512.35 | 89 / 89 | 99% | 3.53 | 892 / 901 |
skin | 100% | 545.41 | 1809 / 1809 | 99% | 3.83 | 467 / 472 |
liver | 100% | 251.71 | 225 / 226 | 99% | 2.85 | 400 / 406 |
adrenal gland | 100% | 514.49 | 258 / 258 | 93% | 3.47 | 213 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 4.69 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.61 | 29 / 29 |
muscle | 100% | 507.73 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 506.62 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 4.32 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.37 | 1 / 1 |
adipose | 100% | 359.53 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 481.51 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 439.93 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 514.96 | 878 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0051301 | Biological process | cell division |
GO_0051445 | Biological process | regulation of meiotic cell cycle |
GO_0090266 | Biological process | regulation of mitotic cell cycle spindle assembly checkpoint |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0005680 | Cellular component | anaphase-promoting complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
Gene name | ANAPC15 |
Protein name | Anaphase-promoting complex subunit 15 (APC15) Anaphase promoting complex subunit 15 Anaphase promoting complex subunit 15 (Chromosome 11 open reading frame 51, isoform CRA_c) |
Synonyms | C11orf51 hCG_23235 HSPC020 |
Description | FUNCTION: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. In the complex, plays a role in the release of the mitotic checkpoint complex (MCC) from the APC/C: not required for APC/C activity itself, but promotes the turnover of CDC20 and MCC on the APC/C, thereby participating in the responsiveness of the spindle assembly checkpoint. Also required for degradation of CDC20. . |
Accessions | ENST00000535503.5 [P60006-1] ENST00000545944.5 [P60006-1] ENST00000539395.1 ENST00000543050.5 F5H3R3 ENST00000535234.5 [P60006-1] ENST00000538117.5 ENST00000438939.6 F5GWM6 ENST00000502597.2 F5H6E4 F5GXB9 F5H2T3 F8WDQ6 ENST00000538919.5 [P60006-1] ENST00000538393.5 [P60006-1] ENST00000537644.5 ENST00000545680.5 [P60006-2] ENST00000227618.9 [P60006-1] ENST00000545333.5 G5EA39 ENST00000542531.5 [P60006-1] ENST00000543587.5 [P60006-2] P60006 |